Key result
Bundle branch block was associated with higher unadjusted 2-year mortality but was not an independent predictor after adjustment, though it predicted reduced LVEF.
Why the study?
Does the presence of a bundle branch block predict 2-year mortality and reduced LVEF in STEMI patients treated in the current era of percutaneous reperfusion therapy?
Cohort (n=1,123)
No
Does the presence of a bundle branch block predict 2-year mortality and reduced LVEF in STEMI patients treated in the current era of percutaneous reperfusion therapy?
Answers are grounded in this paper and cite their sources.
In the contemporary era of primary PCI, the presence of a bundle branch block in STEMI patients is an independent predictor of reduced LVEF, but its association with higher 2-year mortality is driven by baseline comorbidities rather than the conduction block itself.
BACKGROUND: The aim of our study is to assess the effect of bundle branch block (BBB) on mortality and left ventricular ejection fraction (LVEF) in ST-elevation myocardial infarction (STEMI) patients treated in the current era of percutaneous reperfusion therapy. PATIENTS AND METHODS: In this retrospective cohort study, a total of 1123 STEMI patients treated in the University Medical Center Groningen from January 2011 until May 2013 were included. The follow-up duration was 2-4 years. Transthoracic echocardiography was performed within 2 weeks after STEMI. RESULTS: In total, 23 (2.0%) patients presented with left BBB and 49 (4.4%) patients presented with right BBB. Two-year mortality after STEMI was 25.0% (n=18) in patients with BBB and 9.2% (n=97, P<0.001) in patients without BBB. Patients with BBB had more frequently a severely reduced LVEF (<30%) [20.0% (n=6) compared with 4.2% (n=21), P=0.002] and less frequently a normal LVEF [16.7% (n=5) compared with 35.7% (n=179), P=0.046]. After multivariable analysis, BBB did not remain an independent predictor of mortality, but was an independent predictor of reduced LVEF. CONCLUSION: The presence of a BBB was an independent predictor of a reduced LVEF. However, we found no effect of BBB on 2-year mortality in the current era of percutaneous reperfusion therapy.
No takes yet. Share an insight, caveat, or question.
Ende et al. (2016) conducted a cohort in ST-elevation myocardial infarction (n=1,123). Bundle branch block vs. No bundle branch block was evaluated on 2-year mortality (HR 3.433, 95% CI 2.063-5.713, p=<0.001). Bundle branch block was associated with higher unadjusted 2-year mortality but was not an independent predictor after adjustment, though it predicted reduced LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: